Autres langues ACell, Inc.

Actions

ACLL

US00444J1025

Equipement, fournitures et distribution médicale

Temps Différé Nasdaq Autres places de cotation			Varia. 5j.	Varia. 1 janv.
- ^USD	-.--%		-.--%	-

13/05/21

Small & Midcaps : les derniers choix des stars de la gestion

Autres langues

20/01/21	Integra LifeSciences Holdings Corporation completed the acquisition of ACell, Inc for approximately $410 million.
22/12/20	ACell, Inc. Announces CE Mark Approval
16/12/20	Integra LifeSciences Holdings Corporation entered into a definitive agreement to acquire ACell, Inc. for $400 million.
20/07/20	ACell, Inc. has withdrawn its IPO in the amount of $80 million.
26/06/20	ACell, Inc. has filed an IPO in the amount of $86.25 million.
05/09/19	ACell, Inc. Announces Launch of their New Product, Gentrix Hiatal at the 2019 Society of Laparoendoscopic Surgeons Minimally Invasive Surgery Week 2019 in New Orleans, Louisiana
04/09/19	ACell, Inc. and Southmedic Announce Canadian Launch of Gentrix Surgical Matrix Family of Products
08/04/19	ACell, Inc. Enters into Exclusive Long-Term Product Supply and Distribution Agreement with First Horizon, LLC and Weihai Jierui Medical Products Co., Ltd
15/10/18	ACell, Inc. and Southmedic Announce Canadian Launch of Cytal Wound Matrix and MicroMatrix
08/10/18	ACell's Gentrix Surgical Matrix Provides Exceptional Long-Term Results in Complex Patient Populations for Durable Reinforcement of Ventral Hernias
20/07/18	ACell to Host Grand Opening and Ribbon Cutting for Medical Learning Center
08/05/18	ACell, Inc. Names Nino Pionati as Vice President, International and Business Development
11/04/18	ACell, Inc. Announces Launch of Gentrix® Incisional
21/02/18	ACell, Inc. Announces New Distribution Agreement with Applied Tissue Technologies LLC
11/01/17	ACell, Inc. Announces Distribution Agreement with Southmedic, Incorporated
31/10/16	ACell, Inc. Appoints Sally Maher to Board of Directors
22/08/16	ACell, Inc. Names Brad Adams as Vice President of Sales
23/03/16	ACell, Inc. Receives FDA Clearance for Concurrent Use of its Wound Management Devices
11/01/16	ACell, Inc. Announces Management Changes
07/01/16	ACell, Inc. Introduces Cytal Wound Matrix for Complex, Full-Thickness Wounds
28/05/15	ACell, Inc. Announces Release of MatriStem Surgical Matrix Plus
16/03/15	ACell, Inc. Appoints David Elliot as Vice President, Marketing
05/01/15	ACell, Inc. Appoints Thomas Gilbert as a Chief Science Officer
16/12/14	ACell, Inc. Announces Management Changes
15/07/14	ACell, Inc. Announces First Patient in A U.S. Phase IV Clinical Trial